格瑞妥单抗
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
CAS2413817-97-5
Storage conditionShipping with blue ice.
Security information
Product details

Gresonitamab is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody that targets CD3-positive T cells and CLDN18.2-expressing tumor cells, with potential immunostimulatory and antineoplastic activities. It activates and proliferates T-cells, leading to the lysis of CLDN18.2-expressing tumor cells, Gresonitamab can be used for the research of adenocarcinoma.

Related literature
Related
Sorry, no related items
History
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
Bimagrumab (Synonyms: Anti-ACVR2B Reference Antibody; BYM338)
Gatipotuzumab | PankoMab
Anti-Human BCMA Monoclonal Antibody(Belantamab biosimilar) mAb; GSK2857914
Vedolizumab
Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody)
ABX-IL8
Lerdelimumab
Conatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)